We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-1.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$29.6B
AUM Growth
-$295M
Cap. Flow
+$533M
Cap. Flow %
1.8%
Top 10 Hldgs %
19.94%
Holding
3,681
New
221
Increased
1,693
Reduced
1,498
Closed
186

Sector Composition

Rank Sector Weight
1 Technology 10.67%
2 Financials 5.49%
3 Consumer Discretionary 3.63%
4 Healthcare 3.13%
5 Communication Services 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOHO
3476
DELISTED
Sotherly Hotels
SOHO
$13K ﹤0.01%
18,008
-5,500
-23% -$4.53K
TRIB
3477
Trinity Biotech
TRIB
$7.86M
$13K ﹤0.01%
743
MBRX icon
3478
Moleculin Biotech
MBRX
$3.71M
$12K ﹤0.01%
+511
New +$17.2K
PLBY icon
3479
Playboy Inc
PLBY
$149M
$12K ﹤0.01%
10,674
-2,645
-20% -$4.13K
PSNY icon
3480
Polestar Automotive Holding UK
PSNY
$1.99B
$11K ﹤0.01%
359
+2
+0.6% +$66
SKYQ
3481
Sky Quarry Inc
SKYQ
$16.4M
$11K ﹤0.01%
+2,426
New +$18.1K
CLSD
3482
DELISTED
Clearside Biomedical
CLSD
$10K ﹤0.01%
700
LXRX icon
3483
Lexicon Pharmaceuticals
LXRX
$1.05B
$10K ﹤0.01%
22,075
-1,538
-7% -$970
RVSNW icon
3484
Rail Vision Ltd Warrant
RVSNW
$721K
$8K ﹤0.01%
+88,122
New +$13.3K
STEM icon
3485
Stem
STEM
$48.8M
$8K ﹤0.01%
1,202
+58
+5% +$672
TRUG icon
3486
TruGolf
TRUG
$1M
$7K ﹤0.01%
39
+18
+86% +$4.2K
ACXP icon
3487
Acurx Pharmaceuticals
ACXP
$6.62M
$6K ﹤0.01%
750
-138
-16% -$1.86K
AMRN
3488
Amarin Corp
AMRN
$297M
$6K ﹤0.01%
627
+110
+21% +$1.16K
TNYA icon
3489
Tenaya Therapeutics
TNYA
$171M
$6K ﹤0.01%
+11,186
New +$11K
VRCA icon
3490
Verrica Pharmaceuticals
VRCA
$87.4M
$5K ﹤0.01%
1,150
SCWO icon
3491
374Water
SCWO
$40.6M
$3K ﹤0.01%
1,000
XAIR icon
3492
Beyond Air
XAIR
$5.37M
$3K ﹤0.01%
29
TALKW
3493
DELISTED
Talkspace Inc Warrant
TALKW
$1K ﹤0.01%
10,550
FFAIW
3494
DELISTED
Faraday Future Intelligent Electric Warrant
FFAIW
$1K ﹤0.01%
20,000
AAOI icon
3495
Applied Optoelectronics
AAOI
$11.7B
-10,200
Closed -$376K
ACA icon
3496
Arcosa
ACA
$7.12B
-2,159
Closed -$209K
ACVA icon
3497
ACV Auctions
ACVA
$1.35B
-12,691
Closed -$274K
ADIL
3498
Adial Pharmaceuticals
ADIL
$9.43M
-1,080
Closed -$27K
AFIF icon
3499
Anfield Universal Fixed Income ETF
AFIF
$228M
-17,406
Closed -$159K
AFRM icon
3500
Affirm
AFRM
$24.6B
-10,627
Closed -$647K

Similar funds

Cambridge Investment Research Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Cambridge Investment Research Advisors held 3,681 positions worth $29.6B, down 0.99% from $29.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q1 2025 filing shows 221 new, 1,693 increased, 1,498 reduced and 186 closed positions. Its largest new stake was Hartford Large Cap Growth ETF: 374,858 shares worth $7.82M. The largest sale was iShares 0-3 Month Treasury Bond ETF, an estimated $53.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q1 2025 buy was Hartford Large Cap Growth ETF: 374,858 shares worth $7.82M.
  • Cambridge Investment Research Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $39.2M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2025 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $53.2M.
  • Cambridge Investment Research Advisors fully exited JPMorgan BetaBuilders US Mid Cap Equity ETF in Q1 2025, selling an estimated $5.47M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $29.6B portfolio in Q1 2025.
  • Cambridge Investment Research Advisors opened 221 new positions and closed 186 in Q1 2025.
  • Cambridge Investment Research Advisors's portfolio value fell 0.99% quarter-over-quarter to $29.6B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.